Page last updated: 2024-09-03

rufinamide and Adolescent Myoclonic Epilepsy

rufinamide has been researched along with Adolescent Myoclonic Epilepsy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boor, R; Coppola, G; Dahlin, M; Kluger, G; Lotte, J; Mueller, A; Staudt, M; Striano, P; von Stuelpnagel, C	1

Other Studies

1 other study(ies) available for rufinamide and Adolescent Myoclonic Epilepsy

Article	Year
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome. Epilepsy & behavior : E&B, 2011, Volume: 21, Issue:3 Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Longitudinal Studies; Male; Myoclonic Epilepsy, Juvenile; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Retrospective Studies; Seizures, Febrile; Sodium Channels; Treatment Outcome; Triazoles; Young Adult	2011

Article

Year

Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome.

Epilepsy & behavior : E&B, 2011, Volume: 21, Issue:3

Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Female; Humans; Longitudinal Studies; Male; Myoclonic Epilepsy, Juvenile; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Retrospective Studies; Seizures, Febrile; Sodium Channels; Treatment Outcome; Triazoles; Young Adult

2011